Samsung Bioepis Nudges Closer To Ranibizumab Approvals With New Data

Similarity Data To Be Presented At 2021 ARVO Meeting

 
• By Dean Rudge
  
Eye
The first biosimilar to Lucentis is expected to launch in the US in the second half of 2021 • Source: Shutterstock

More from Biosimilars

More from Products